Waldemar Gonsiorek

2.5k total citations
28 papers, 2.0k citations indexed

About

Waldemar Gonsiorek is a scholar working on Immunology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Waldemar Gonsiorek has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Waldemar Gonsiorek's work include Chemokine receptors and signaling (12 papers), Cannabis and Cannabinoid Research (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Waldemar Gonsiorek is often cited by papers focused on Chemokine receptors and signaling (12 papers), Cannabis and Cannabinoid Research (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Waldemar Gonsiorek collaborates with scholars based in United States, United Kingdom and Switzerland. Waldemar Gonsiorek's co-authors include R. William Hipkin, Daniel Lundell, Satwant K. Narula, Xuedong Fan, Charles A. Lunn, Jay S. Fine, Gregory Deno, Paul J. Zavodny, Joseph A. Kozlowski and Marvin Bayne and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Waldemar Gonsiorek

28 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waldemar Gonsiorek United States 19 933 552 514 450 336 28 2.0k
R. William Hipkin United States 29 792 0.8× 1.1k 2.1× 611 1.2× 648 1.4× 725 2.2× 47 3.0k
Lorraine Malkowitz United States 17 593 0.6× 554 1.0× 65 0.1× 381 0.8× 219 0.7× 22 1.5k
P Carayon France 28 704 0.8× 932 1.7× 143 0.3× 400 0.9× 370 1.1× 98 3.1k
Douglas R. McDonald United States 19 643 0.7× 687 1.2× 165 0.3× 133 0.3× 267 0.8× 33 2.3k
David Beidler United States 22 332 0.4× 1.1k 2.0× 662 1.3× 310 0.7× 242 0.7× 30 2.1k
Zen‐ichiro Honda Japan 23 758 0.8× 1.4k 2.6× 157 0.3× 226 0.5× 287 0.9× 57 2.7k
Dulcie B. Schmidt United States 27 592 0.6× 891 1.6× 149 0.3× 419 0.9× 558 1.7× 55 2.4k
Huiyi Miao United States 13 193 0.2× 744 1.3× 456 0.9× 221 0.5× 173 0.5× 20 1.8k
Brian Gardner United States 18 787 0.8× 494 0.9× 712 1.4× 664 1.5× 126 0.4× 27 2.1k
Desmond T. Walsh United Kingdom 13 443 0.5× 426 0.8× 107 0.2× 394 0.9× 148 0.4× 21 1.6k

Countries citing papers authored by Waldemar Gonsiorek

Since Specialization
Citations

This map shows the geographic impact of Waldemar Gonsiorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldemar Gonsiorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldemar Gonsiorek more than expected).

Fields of papers citing papers by Waldemar Gonsiorek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldemar Gonsiorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldemar Gonsiorek. The network helps show where Waldemar Gonsiorek may publish in the future.

Co-authorship network of co-authors of Waldemar Gonsiorek

This figure shows the co-authorship network connecting the top 25 collaborators of Waldemar Gonsiorek. A scholar is included among the top collaborators of Waldemar Gonsiorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldemar Gonsiorek. Waldemar Gonsiorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ménard, Laurence, Waldemar Gonsiorek, Deborah Lee, et al.. (2016). B cells from African American lupus patients exhibit an activated phenotype. JCI Insight. 1(9). e87310–e87310. 38 indexed citations
2.
Tong, Ling, Lei Chen, Razia Rizvi, et al.. (2010). Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(22). 6785–6789. 19 indexed citations
3.
Wang, Yuanfan, Long Cui, Waldemar Gonsiorek, et al.. (2009). CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. Journal of Inflammation. 6(1). 32–32. 46 indexed citations
4.
Min, Soo, Yuanfan Wang, Waldemar Gonsiorek, et al.. (2009). Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochemical and Biophysical Research Communications. 391(1). 1080–1086. 52 indexed citations
5.
Chapman, Richard W., Michael Minnicozzi, Chander Celly, et al.. (2007). A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation. Journal of Pharmacology and Experimental Therapeutics. 322(2). 486–493. 116 indexed citations
6.
Gonsiorek, Waldemar, Charles A. Lunn, Xuerong Fan, et al.. (2007). Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates. British Journal of Pharmacology. 151(8). 1262–1271. 14 indexed citations
7.
Gonsiorek, Waldemar, David Hesk, Shu‐Cheng Chen, et al.. (2006). Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336. Journal of Biological Chemistry. 281(38). 28143–28151. 20 indexed citations
8.
Lunn, Charles A., Jay S. Fine, Alberto Rojas-Triana, et al.. (2006). A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo. Journal of Pharmacology and Experimental Therapeutics. 316(2). 780–788. 112 indexed citations
9.
Fan, Xuedong, Andriani C. Patera, Gregory Deno, et al.. (2006). Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8. Journal of Biological Chemistry. 282(16). 11658–11666. 171 indexed citations
10.
Lavey, Brian J., Joseph A. Kozlowski, R. William Hipkin, et al.. (2005). Triaryl Bis‐sulfones as a New Class of Cannabinoid CB2 Receptor Inhibitors: Identification of a Lead and Initial SAR Studies.. ChemInform. 36(25). 2 indexed citations
11.
Shankar, Bandarpalle B., Brian J. Lavey, Guowei Zhou, et al.. (2005). Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies. Bioorganic & Medicinal Chemistry Letters. 15(20). 4417–4420. 24 indexed citations
12.
Fossetta, James, Gregory Deno, Waldemar Gonsiorek, et al.. (2004). Pharmacological characterization of human S1P4 using a novel radioligand, [4,5‐3H]‐dihydrosphingosine‐1‐phosphate. British Journal of Pharmacology. 142(5). 851–860. 9 indexed citations
13.
Hipkin, R. William, Gregory Deno, Jay S. Fine, et al.. (2004). Cloning and Pharmacological Characterization of CXCR1 and CXCR2 from Macaca fascicularis. Journal of Pharmacology and Experimental Therapeutics. 310(1). 291–300. 11 indexed citations
14.
Yang, Shu‐Wei, Tze‐Ming Chan, Shirley A. Pomponi, et al.. (2003). A New Sesterterpene, Sch 599473, from a Marine Sponge, Ircinia sp.. The Journal of Antibiotics. 56(9). 783–786. 14 indexed citations
15.
Gonsiorek, Waldemar, Paul J. Zavodny, & R. William Hipkin. (2003). The study of CXCR3 and CCR7 pharmacology using [35S]GTPγS exchange assays in cell membranes and permeabilized peripheral blood lymphocytes. Journal of Immunological Methods. 273(1-2). 15–27. 11 indexed citations
16.
Chou, Chuan‐Chu, Jay S. Fine, Catherine Pugliese‐Sivo, et al.. (2002). Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL‐60 cells: antagonism of hCCR1 activation by MIP‐1β. British Journal of Pharmacology. 137(5). 663–675. 31 indexed citations
17.
Anthes, JC, Shelby P. Umland, You Wan, et al.. (2001). Cloning and characterization of a novel human histamine receptor.. PubMed. 296(3). 1058–66. 232 indexed citations
18.
Pugliese‐Sivo, Catherine, et al.. (2001). HUMAN B CELL-ATTRACTING CHEMOKINE 1 (BCA-1; CXCL13) IS AN AGONIST FOR THE HUMAN CXCR3 RECEPTOR. Cytokine. 15(3). 113–121. 71 indexed citations
19.
Gonsiorek, Waldemar, Charles A. Lunn, Xuedong Fan, et al.. (2000). Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide. Molecular Pharmacology. 57(5). 1045–1050. 305 indexed citations
20.
Sugár, István P., et al.. (1997). Kinetic Studies of Desensitization and Resensitization of the Relaxation Response to Beta-2 Adrenoceptor Agonists in Isolated Guinea Pig Trachea. Journal of Pharmacology and Experimental Therapeutics. 280(1). 332–345. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. William Hipkin Breakdown of academic impact, for papers by Lorraine Malkowitz Breakdown of academic impact, for papers by P Carayon Breakdown of academic impact, for papers by Douglas R. McDonald Breakdown of academic impact, for papers by David Beidler Breakdown of academic impact, for papers by Zen‐ichiro Honda Breakdown of academic impact, for papers by Dulcie B. Schmidt Breakdown of academic impact, for papers by Huiyi Miao Breakdown of academic impact, for papers by Brian Gardner Breakdown of academic impact, for papers by Desmond T. Walsh
Rankless by CCL
2026